(Total Views: 184)
Posted On: 11/04/2020 9:48:23 AM
Post# of 4861
InMed Pharmaceuticals to Report First Quarter Fiscal 2021 Financial Results and Business Update on November 6, 2020
Vancouver, BC – November 4, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (CBN), will report financial results for the first quarter of fiscal year 2021 ending September 30, 2020 (1Q21), on Friday, November 6, 2020.
Conference Call & Webcast:
Friday, November 6, 2020 at 9:30 AM Pacific Time, 12:30 PM Eastern Time
Local - Toronto (+1) 416-764-8609
Local - Vancouver (+1) 778-383-7417
Toll Free - North America (+1) 888-390-0605
Conference ID: 63132506
Webcast: https://produceredition.webcasts.com/starther...22aaf86755
Replays, Available Through November 13, 2020
Toronto: (+1) 416-764-8677
North America (Toll Free): (+1) 888-390-0541
Playback Passcode: 132506 #
The Company’s full financial statements and related MD&A for the fiscal quarter ended September 30, 2020 will be available on the morning of November 6th at www.inmedpharma.com and at www.sedar.com.
Vancouver, BC – November 4, 2020 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way in the clinical development of cannabinol (CBN), will report financial results for the first quarter of fiscal year 2021 ending September 30, 2020 (1Q21), on Friday, November 6, 2020.
Conference Call & Webcast:
Friday, November 6, 2020 at 9:30 AM Pacific Time, 12:30 PM Eastern Time
Local - Toronto (+1) 416-764-8609
Local - Vancouver (+1) 778-383-7417
Toll Free - North America (+1) 888-390-0605
Conference ID: 63132506
Webcast: https://produceredition.webcasts.com/starther...22aaf86755
Replays, Available Through November 13, 2020
Toronto: (+1) 416-764-8677
North America (Toll Free): (+1) 888-390-0541
Playback Passcode: 132506 #
The Company’s full financial statements and related MD&A for the fiscal quarter ended September 30, 2020 will be available on the morning of November 6th at www.inmedpharma.com and at www.sedar.com.
(1)
(0)
